Clinical trials: Male Erectile Dysfunction
Vasculogenic Erectile Dysfunction
Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Vascular Erectile Dysfunction
Evidence has been arising that Botulinum toxin injections can relax smooth muscles fibers in the treatment of obesity and hyperactive bladder.
- Trial name
- NCT02584686
- Testing
- Botulinum Toxin Type A, Normal Saline
- Where
- Egypt
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Cairo University
Urinary Incontinence, Erectile Dysfunction
Effectiveness of Physiotherapy to Treat the Urinary Incontinence and Erectile Dysfunction Post Retropubic Prostatectomy
The prostate cancer is the most common parenchymal neoplasia in men over 45 years old. Radical prostatectomy is curative treatment is most used today.
- Trial name
- NCT02226237
- Testing
- group of pelvic floor exercises, anal electrostimulation group
- Where
- Brazil
- Volunteers
- 237 people
- Sponsor
- Barretos Cancer Hospital
Impotence
Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction
Assessment of duration of action, safety \& toleration of different formulations and doses of UK-369,003 and Cialis in patients with male erectile dysfunction.
- Trial name
- NCT00174486
- Testing
- UK0369,003, Cialis (Tadalafil)
- Volunteers
- 300 people
- Sponsor
- Pfizer
Erectile Dysfunction
To Assess the Safety of Avanafil in Healthy and Hepatically Impaired Male Subjects.
The objective of this study is to assess the single dose pharmacokinetics of avanafil in subjects with hepatic impairment and in healthy control subjects.
- Trial name
- avanafil (NCT01054430)
- Testing
- avanafil
- Volunteers
- 27 people, healthy volunteers welcome
- Sponsor
- VIVUS LLC
Impotence, Erectile Dysfunction
The Management of Erectile Dysfunction With Placebo Only
Placebo-controlled randomized clinical trials (RCT) are the gold standard to provide applicable evidence for clinical practice. A vast number of RCTs for treatment of several disorders has shown a mean placebo effect of 30%.
- Trial name
- DAFA06 (NCT00882934)
- Testing
- Induction to efficient treatment, Doubt to the efficacy of treatment, Induction to ineffective treatment
- Volunteers
- 123 people
- Sponsor
- Rio de Janeiro State University
Erectile Dysfunction
Low Intensity Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction- 4 Arms
Low intensity shock waves(LISW) have been proven in animal studies to induce local growth of new blood vessels. The investigators hypothesized that LISW therapy could improve the symptoms of patients with erectile dysfunction…
- Trial name
- NCT01442077
- Testing
- Extracorporeal Shockwave Therapy Generator (Omnispec ED1000)
- Where
- Israel
- Volunteers
- 200 people
- Sponsor
- Rambam Health Care Campus
Erectile Dysfunction
Study Evaluating the Efficacy and Safety of Flexible-dose Vardenafil in Subjects With Erectile Dysfunction
Study to investigate the efficacy and safety of Vardenafil
- Trial name
- NCT00658177
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Volunteers
- 463 people
- Sponsor
- Bayer
Heart Failure, Heart Failure, Systolic
COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure
The purpose of this study was to determine the effect of sacubitril/valsartan (LCZ696) vs. Enalapril on improvement in erectile function and ability in male patients with chronic heart failure with reduced ejection fraction and…
- Conditions
- Heart Failure, Heart Failure, Systolic, Erectile Dysfunction
- Trial name
- CONFIDENCE-HF (NCT03917459)
- Testing
- LCZ696, Enalapril
- Where
- 13 sites in Germany
- Volunteers
- 27 people
- Sponsor
- Novartis Pharmaceuticals
Erectile Dysfunction Associated With Type 2 Diabetes Mellitus
Safety of Wharton Jelly in Erectile Dysfunction
Safety of Intracavernous injection of Wharton jelly Mesenchymal stem cells for the treatment of erectile dysfunction in diabetic patients.
- Trial name
- NCT02945449
- Testing
- Wharton Jelly Mesenchymal stem cells
- Where
- Jordan
- Volunteers
- 9 people
- Sponsor
- Sophia Al-Adwan
Erectile Dysfunction, Urinary Incontinence
Male Pelvic Floor Muscle Rehabilitation Exercises
Phase I G128 Study Objective The ischiocavernosus (IC) and bulbospongiosus (BS) muscles are vital components of the superficial perineal layer, serving as the foundation for male sexual health and performance.
- Conditions
- Erectile Dysfunction, Urinary Incontinence, Premature Ejaculation
- Trial name
- NCT07451808
- Testing
- Male Pelvic Floor Rehabilitation #1
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Dream Video LLC
Erectile Dysfunction
Pharmacoscintigraphic Study to Evaluate Two Sildenafil Products
The study will assess a new biphasic release sildenafil formulation (N4S001), developed by N4 Pharma. The N4S001 tablet contains a total of 100 mg sildenafil.
- Trial name
- NCT03510338
- Testing
- Sublingual sildenafil, Oral sildenafil
- Where
- United Kingdom
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- N4 Pharma UK Ltd.
Spermatogenesis, Erectile Dysfunction
Effect of Udenafil on Spermatogenesis
Study of udenafil daily in subjects with mild or no erectile dysfunction to evaluate effects on semen characteristics.
- Trial name
- NCT01230541
- Testing
- Udenafil
- Where
- 23 sites in United States
- Volunteers
- 239 people, healthy volunteers welcome
- Sponsor
- Warner Chilcott
Erectile Dysfunction
The Effects of a Nitrate Supplementation on Erectile Function
Twenty (20) individuals to be recruited from Ballantyne Medical Associates in Charlotte, NC, without any significant chronic medical history. These patients are general patients for primary care that meet inclusion criteria.
- Trial name
- NCT06213077
- Testing
- Nitric Oxide, Tadalafil
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- RHA Investments Ltd
Erectile Dysfunction, Stem Cells
Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes
Diabetes is a major concern in public health because of its high frequency and its negative consequences. Erectile dysfunction (ED) is present, regardless of age, in 50 to 75% of men with diabetes.
- Conditions
- Erectile Dysfunction, Stem Cells, Diabetes Mellitus, Type 1
- Trial name
- MESERIC (NCT03361631)
- Testing
- Autologous Bone Marrow derived Mesenchymal Stem Cells
- Volunteers
- 13 people
- Sponsor
- Central Hospital, Nancy, France
Sexual Behavior, Erectile Dysfunction
Male Reproductive Health of Floating Population: a Large-Scale Survey in Dongguan
To determine the prevalence of sexual problems particularly premature ejaculation and erectile dysfunction among men working in factories of Dongguan city, using the self-rating scales like International Index of Erectile…
- Conditions
- Sexual Behavior, Erectile Dysfunction, Premature Ejaculation
- Trial name
- NCT01901029
- Where
- China
- Volunteers
- 3,100 people, healthy volunteers welcome
- Sponsor
- First Affiliated Hospital, Sun Yat-Sen University
Erectile Dysfunction, Acupuncture Therapy
Clinical Efficacy of Acupuncture on the Liver Meridian in Men With Erectile Dysfunction Reserve
Erectile dysfunction (ED) is a kind of worldwide and common sexual dysfunction disease, which mainly affects men over forty years old.
- Conditions
- Erectile Dysfunction, Acupuncture Therapy, Median Nerve Disease
- Trial name
- GJZLBQGNZA (NCT05749354)
- Testing
- electroacupuncture
- Where
- China
- Volunteers
- 159 people
- Sponsor
- The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Erectile Dysfunction
Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension
Assess efficacy of Vardenafil in patients erectile dysfunction and high blood pressure
- Trial name
- NCT00668005
- Testing
- Levitra (Vardenafil, BAY38-9456)
- Volunteers
- 388 people
- Sponsor
- Bayer
Erectile Dysfunction
Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects
It is a single-center, open-label, Phase I clinical study evaluating the safety and pharmacokinetics of a single oral TPN171H in elderly subjects.
- Trial name
- NCT06090136
- Testing
- TPN171H
- Where
- China
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Vigonvita Life Sciences
Erectile Dysfunction
Effect of Intradialytic Exercise on Erectile Dysfunction in Hemodialysis Men
This study aimed to assess the effect of IDEP on ED and its associated psychological burden in HD men. Forty HD men with ED were randomly assigned into the IDEP group (this group contained 20 HD men with ED who received…
- Trial name
- IDEP (NCT06635044)
- Testing
- intradialytic exercise
- Where
- Egypt
- Volunteers
- 40 people
- Sponsor
- Mohammed Mohamed Mazen
Low Risk Prostate Cancer
Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer
Multiple center, single-arm, open-label, 12-month follow-up phase IV pragmatic clinical trial in men with unilateral prostate cancer meeting eligibility criteria for the drug (as per the European Economic Area (EEA) Marketing…
- Trial name
- NCT03849365
- Testing
- TOOKAD VTP
- Where
- France
- Volunteers
- 23 people
- Sponsor
- Steba Biotech S.A.